Hualan Biological Engineering Inc. 002007.SZ Stock
Hualan Biological Engineering Inc. Price Chart
Hualan Biological Engineering Inc. 002007.SZ Financial and Trading Overview
| Hualan Biological Engineering Inc. stock price | 18.95 CNY |
| Previous Close | 22.33 CNY |
| Open | 22.28 CNY |
| Bid | 22.21 CNY x 0 |
| Ask | 22.22 CNY x 0 |
| Day's Range | 22.2 - 22.46 CNY |
| 52 Week Range | 17.01 - 25.09 CNY |
| Volume | 4.72M CNY |
| Avg. Volume | 13.06M CNY |
| Market Cap | 40.54B CNY |
| Beta (5Y Monthly) | 0.34041 |
| PE Ratio (TTM) | 34.184616 |
| EPS (TTM) | 0.81 CNY |
| Forward Dividend & Yield | 0.3 (1.35%) |
| Ex-Dividend Date | June 14, 2023 |
| 1y Target Est | 26.24 CNY |
002007.SZ Valuation Measures
| Enterprise Value | 40.08B CNY |
| Trailing P/E | 34.184616 |
| Forward P/E | 22.907215 |
| PEG Ratio (5 yr expected) | 1.21 |
| Price/Sales (ttm) | 8.521674 |
| Price/Book (mrq) | 3.769296 |
| Enterprise Value/Revenue | 8.426 |
| Enterprise Value/EBITDA | 25.022 |
Trading Information
Hualan Biological Engineering Inc. Stock Price History
| Beta (5Y Monthly) | 0.34041 |
| 52-Week Change | 4.54% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 25.09 CNY |
| 52 Week Low | 17.01 CNY |
| 50-Day Moving Average | 22.8 CNY |
| 200-Day Moving Average | 21.28 CNY |
002007.SZ Share Statistics
| Avg. Volume (3 month) | 13.06M CNY |
| Avg. Daily Volume (10-Days) | 8.42M CNY |
| Shares Outstanding | 1.82B |
| Float | 960.62M |
| Short Ratio | N/A |
| % Held by Insiders | 48.15% |
| % Held by Institutions | 8.88% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.3 |
| Trailing Annual Dividend Yield | 1.34% |
| 5 Year Average Dividend Yield | 92.00% |
| Payout Ratio | 0.306 |
| Last Split Factor | 1.3:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 25.10% |
| Operating Margin (ttm) | 27.55% |
| Gross Margin | 62.75% |
| EBITDA Margin | 33.67% |
Management Effectiveness
| Return on Assets (ttm) | 5.63% |
| Return on Equity (ttm) | 11.55% |
Income Statement
| Revenue (ttm) | 4.76B CNY |
| Revenue Per Share (ttm) | 2.61 CNY |
| Quarterly Revenue Growth (yoy) | 37.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | 1.6B CNY |
| Net Income Avi to Common (ttm) | 1.19B CNY |
| Diluted EPS (ttm) | 0.65 |
| Quarterly Earnings Growth (yoy) | 50.39% |
Balance Sheet
| Total Cash (mrq) | 3.55B CNY |
| Total Cash Per Share (mrq) | 1.95 CNY |
| Total Debt (mrq) | 1.11B CNY |
| Total Debt/Equity (mrq) | 8.81 CNY |
| Current Ratio (mrq) | 3.715 |
| Book Value Per Share (mrq) | 5.895 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.27B CNY |
| Levered Free Cash Flow (ttm) | 98.24M CNY |
Profile of Hualan Biological Engineering Inc.
| Country | China |
| State | N/A |
| City | Xinxiang |
| Address | No. 1 Hualan Avenue A |
| ZIP | 453003 |
| Phone | 86 37 3351 9992 |
| Website | https://www.hualanbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 3243 |
Hualan Biological Engineering Inc., a biopharmaceutical company, researches, develops, produces, and commercializes plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics in the People's Republic of China. Its blood products comprise human albumin, human immunoglobulin, intravenous human immunoglobulin, rabies immunoglobulin, hepatitis B human immunoglobulin, tetanus human immunoglobulin, human prothrombin complex, human coagulation factor VIII, lyophilized human thrombin for external use, freeze-dried human fibrin glue for surgery, and human fibrinogen. The company's vaccines consist of influenza virus split vaccine, recombinant hepatitis B vaccine, ACYW135 meningococcal polysaccharide vaccine, A H1N1 influenza virus split vaccine, and quadrivalent influenza virus split vaccine. The company has strategic alliance with the Chinese Academy of Sciences, and other scientific research institutes and scientific research companies. The company was founded in 1992 and is based in Xinxiang, the People's Republic of China.
Q&A For Hualan Biological Engineering Inc. Stock
What is a current 002007.SZ stock price?
Hualan Biological Engineering Inc. 002007.SZ stock price today per share is 18.95 CNY.
How to purchase Hualan Biological Engineering Inc. stock?
You can buy 002007.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hualan Biological Engineering Inc.?
The stock symbol or ticker of Hualan Biological Engineering Inc. is 002007.SZ.
Which industry does the Hualan Biological Engineering Inc. company belong to?
The Hualan Biological Engineering Inc. industry is Biotechnology.
How many shares does Hualan Biological Engineering Inc. have in circulation?
The max supply of Hualan Biological Engineering Inc. shares is 1.83B.
What is Hualan Biological Engineering Inc. Price to Earnings Ratio (PE Ratio)?
Hualan Biological Engineering Inc. PE Ratio is 23.39506300 now.
What was Hualan Biological Engineering Inc. earnings per share over the trailing 12 months (TTM)?
Hualan Biological Engineering Inc. EPS is 0.81 CNY over the trailing 12 months.
Which sector does the Hualan Biological Engineering Inc. company belong to?
The Hualan Biological Engineering Inc. sector is Healthcare.